Key Segmentation
By Technology
-
Quantum Hardware Platforms
-
Quantum Software Platforms
-
Quantum Algorithms
-
Hybrid Quantum-Classical Computing
-
Quantum Cloud Services
By Deployment Model
-
Cloud-Based Quantum Computing
-
On-Premise Quantum Infrastructure
-
Hybrid Quantum-Classical Platforms
-
Quantum-as-a-Service (QaaS)
By Application
-
Target Identification & Validation
-
Molecular Simulation & Quantum Chemistry
-
Lead Discovery & Optimization
-
Protein Folding & Bimolecular Modelling
-
ADMET Prediction
By End User
-
Pharmaceutical Companies
-
Biotechnology Companies
-
Contract Research Organizations (CROs)
-
Academic & Research Institutes
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the global market in 2025 with approximately 47.00% revenue share.
Asia Pacific is projected to register the fastest CAGR of 17.27% during 2026–2035.
The market is expected to expand at a CAGR of 12.61% during the forecast period.
The market is projected to reach USD 1.47 Billion by 2035.
The Quantum Computing In Drug Discovery Market was valued at USD 0.45 Billion in 2025.